Fusion Pharmaceuticals Inc logo

FUSN - Fusion Pharmaceuticals Inc News Story

$8.56 0.0  0.0%

Last Trade - 21/09/21

Sector
Healthcare
Size
Small Cap
Market Cap £269.6m
Enterprise Value £138.9m
Revenue £381k
Position in Universe 4085th / 7157

BRIEF-Fusion Pharmaceuticals Announces Preliminary Safety And Dosimetry Results From Its Single-Dose Portion Of The Phase 1 Study Of Fpi-1434

Mon 14th June, 2021 10:35pm
June 14 (Reuters) - Fusion Pharmaceuticals Inc  FUSN.O :
    * FUSION PHARMACEUTICALS ANNOUNCES PRELIMINARY SAFETY AND
DOSIMETRY RESULTS FROM ITS SINGLE-DOSE PORTION OF THE PHASE 1
STUDY OF FPI-1434
    * FUSION PHARMACEUTICALS INC - IMAGING SHOWS DRUG UPTAKE
ACROSS
MULTIPLE TUMOR TYPES
    * FUSION PHARMACEUTICALS INC - ENROLLMENT IN MULTI-DOSING
COHORTS
CONTINUES

Source text for Eikon:  ID:nCNWnhLRYa 
Further company coverage:  FUSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.